# Intralesional HPV Vaccine for Condylomata

> **NCT05087849** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 2 (actual)

## Conditions studied

- Human Papilloma Virus
- Warts
- Warts, Genital
- Condyloma
- Condylomata Acuminata

## Interventions

- **BIOLOGICAL:** nonavalent human papillomavirus vaccine

## Key facts

- **NCT ID:** NCT05087849
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-15
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05087849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05087849, "Intralesional HPV Vaccine for Condylomata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05087849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*